Since AIB1 can promote the proliferation and invasion of HCC cells [15], the inhibitory effects of AIB1 downregulation on HCC cell proliferation and invasion may also contribute to the anti-tumor effects of sorafenib on HCC. This evidence concerns the gene NCOA3 and neoplasm.